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Abstract: Research synthesis seeks to gather, examine and evaluate systematically research reports that converge toward 
answering a carefully crafted research question, which states the problem patient population, the intervention under con-
sideration, and the clinical outcome of interest. The product of the process of systematically reviewing the research litera-
ture pertinent to the research question thusly stated is the “systematic review”. 
The objective and transparent approach of the systematic review aims to minimize bias. Most systematic reviews yield 
quantitative analyses of measurable data (e.g., acceptable sampling analysis, meta-analysis). Systematic reviews may also 
be qualitative, while adhering to accepted standards for gathering, evaluating, and reporting evidence. Systematic reviews 
provide highly rated recommendations for evidence-based health care; but, systematic reviews are not equally reliable and 
successful in minimizing bias. 
Several instruments are available to evaluate the quality of systematic reviews. The 'assessment of multiple systematic re-
views' (AMSTAR) was derived from factor analysis of the most relevant items among them. AMSTAR consists of eleven 
items with good face and content validity for measuring the methodological quality of systematic reviews, has been 
widely accepted and utilized, and has gained in reliability, reproducibility. AMSTAR does not produce quantifiable as-
sessments of systematic review quality and clinical relevance.  
In this study, we have revised the AMSTAR instrument, detracting nothing from its content and construct validity, and 
utilizing the very criteria employed in the development of the original tool, with the aim of yielding an instrument that can 
quantify the quality of systematic reviews. We present validation data of the revised AMSTAR (R-AMSTAR), and dis-
cuss its implications and application in evidence-based health care.  
INTRODUCTION 
The new science of research synthesis has emerged from 
the seminal work of Archibald Cochrane (1909-1988) in 
health care over the last four decades [1]. The principal aim 
of research synthesis is to gather, to examine and to evaluate 
systematically research reports that converge toward answer-
ing a carefully developed research question. The question is 
crafted so as to state clearly and unequivocally the problem 
patient population (P), the intervention (I) under considera-
tion (C), and the clinical outcome (O) of interest. The prod-
uct of the process of systematically reviewing the research 
literature pertinent to the research question (P.I.C.O.) thusly 
stated has been termed the “systematic review” [2-4]. 
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The systematic review is not identical to the literature re-
view because it rests upon an objective and transparent ap-
proach, which is grounded on the science of research synthe-
sis with the specific intent and goal to minimize bias. To that 
end, most systematic reviews are based on an explicit quanti-
tative analysis of measurable data (e.g., acceptable sampling 
analysis, meta-analysis). Despite these concerted efforts, 
certain threats of bias subsist (e.g., publication bias). Moreo-
ver, a substantial number of systematic reviews are qualita-
tive in nature, and, while adhering to accepted standards for 
gathering, evaluating, and reporting evidence, do not yield 
quantitative assessments [4].  
Consequently, while systematic reviews provide, in prin-
ciple, the most highly rated recommendations for evidence-
based health care, it is now evident that, in actuality, not all 
systematic reviews are equally as reliable and of sufficient 
quality to minimize bias satisfactorily [5]. Other sources of 
divergence, or “discordance”, in systematic reviews arise 
from the fundamental need of regular updates. A brief survey 
of the pertinent body literature, or “bibliome”, suggests that From Systematic Reviews to Clinical Recommendations  The Open Dentistry Journal, 2010, Volume 4    85 
at least 10% of all systematic reviews in health care need 
updating at the time of publication because of the length of 
time taken in preparing a systematic review, and of the ac-
celerated pace of scientific production of new evidence [6]. 
Moreover, systematic reviews may employ and incorporate 
“gray literature” (e.g., unpublished observations, disserta-
tions, conference proceedings) to different extents in an ef-
fort to be all-inclusive of the available literature [13,4,7]. 
These disparities in protocol contribute to yielding a con-
fused and often conflicting bibliome of discordant systematic 
reviews, which seems to complicate, rather than to ease the 
process of clinical evidence-based decision-making in health 
care [3,8,9]. 
To confront this important problem, several instruments 
have been developed and validated in order to evaluate the 
quality of systematic reviews, starting with a simple check-
list over 15 years ago [10], and soon evolving into the more 
cumbersome Overview Quality Assessment Questionnaire 
(OQAQ) [11]. In an effort to develop an instrument to assess 
the methodological quality of systematic reviews, building 
upon previous tools, empirical evidence and expert consen-
sus, a 37-item assessment tool was devised by combining the 
items of the OQAQ, an expanded checklist [12], and three 
additional items considered methodologically relevant. This 
hybrid tool was validated with close to 150 systematic re-
views, and factor analyzed so as to identify underlying com-
ponents. Items were reduced to eleven in the creation of the 
'assessment of multiple systematic reviews' (AMSTAR) [13]. 
Careful psychometric assessments determined that AM-
STAR has good face and content validity for measuring the 
methodological quality of systematic reviews and clinical 
relevance. As of this date, AMSTAR has been widely ac-
cepted and utilized by professional health care associations 
and other policy institutions, and has gained in respectability, 
reliability, reproducibility. AMSTAR, while appropriate and 
user-friendly, fails to produce quantifiable assessments of 
systematic review quality [1,8,9,13].  
We have revised AMSTAR, detracting nothing from its 
content and construct validity, utilizing the criteria originally 
employed in its development, and produced the revised AM-
STAR (R-AMSTAR) that successfully quantifies the quality 
of systematic reviews (Appendix 1). Here, we present and 
discuss its validation in evidence-based clinical decision-
making health care.  
METHOD 
We selected at random two independent domains of 
clinical work in health care: post-traumatic stress syndrome 
(PTSD), and rheumatoid arthritis (RA). We appropriately 
crafted a P.I.C.O. question for each domains, which sug-
gested medical subject heading keywords for inclusion and 
exclusion purposes. We searched the National Library or 
Medicine (Pubmed, Medline), Google Scholar, Cochrane 
Library, Center for Reviews & Dissemination, and EM-
BASE, and supplemented the yield by manual search of the 
literature. We excluded systematic reviews that were not in 
English, “gray literature”, literature reviews that were not 
systematic reviews by the criteria of be centered around a 
clearly stated P.I.C.O. question, and any primary research 
report (i.e., clinical trial, observational study). 
We trained four independent readers, and ensured their 
ability to read critically and following the criteria of R-
AMSTAR (cf., Appendix 1) in a standard manner by running 
blind mock critical R-AMSTAR assessment sessions of the 
same systematic review, and comparing the outcomes. Any 
divergent response was discussed until consensus was 
reached as to how, specifically, the criteria of R-AMSTAR 
ought to be applied for each of the eleven domains. 
Two readers focused on the PTSD systematic reviews, 
and the other two readers concerned themselves with the RA 
systematic reviews. Readings were independent and blind 
from each other. Data were pooled for each bibliome, aver-
aged, and analyzed quantitatively by a fifth member of the 
research team to ensure unbiased and blind analyses and 
interpretations. 
Acceptable sampling analysis was performed as de-
scribed (3,8), using the Friedman test for non-parametric 
analysis of factorial designs, followed by non-parametric 
post-hoc comparisons, and Bonferroni correction of the level 
of significance (=0.05) as needed (MDAS statistical soft-
ware: Medical Data Analysis System, EsKay Software, 
Pittsburgh, 2004). In brief, scores from both readers in each 
bibliome were tabulated across the eleven domains of the 
original AMSTAR scored based on the original criteria as 
described in Appendix 1. Marginal totals were utilized to 
establish the level of acceptability within a 95% confidence 
interval (CI95). The relative strength of each domain was 
described by their respective means and coefficient of varia-
tion, and inclusion within the respective CI95 for each do-
main, and compared when needed, by Wilcoxon (MDAS), 
with Bonferroni correction as noted. 
RESULTS 
In systematic reviews, a flowchart is often presented that 
lists the process by which the bibliome of pertinent literature 
is progressively obtained by inclusion and exclusion criteria. 
Lest the present report be misconstrued as a systematic re-
view, we do not present the information in that format here. 
The present study used, as its unit of research, not individual 
primary research reports (e.g., clinical trials), but existing 
systematic reviews. Whereas systematic reviews seek to 
identify the best available evidence within a given bibliome 
for or against a certain treatment intervention, the intent of 
the data we present here is not that: rather, it seeks to utilize 
a coherent and homogeneous bibliome in a health science 
topic to verify the validity of our approach to quantify AM-
STAR-derived assessments of systematic review quality.  
With this intent, suffice to say that, from an original 
search of systematic reviews, we obtained 394 pertinent en-
tries for PTSD, and 970 entries for RA. Upon, filtering for 
intervention and for inflammation respectively, the number 
of PTSD and RA systematic reviews decreased respectively 
to 72 and 71. Further filtering (psychological treatment, in-
flammation bone) lowered the number of coherent system-
atic reviews to 20 for PTSD and 10 for RA. Upon verifica-
tion of outcome homogeneity and language, a final total of 
11 systematic reviews for PTSD and of 5 systematic reviews 
for RA were obtained, and used in the validation study. 
The data shown in Table 1 list the average scores for R-
AMSTAR for the PTSD literature. The inter-rate reliability 86    The Open Dentistry Journal, 2010, Volume 4  Kung et al. 
for this set was 0.58. Table 2 lists the average scores for R-
AMSTAR for the RA literature, where the inter-rate reliabil-
ity obtained 64% of shared variance (Pearson r=0.80). 
The data in Table 1 show that all of the systematic re-
views examined in PTSD had a R-AMSTAR a score that fell 
within the confidence interval set by the sample 
(mean+standard deviation: 31.45+3.37, CI95: 24.8 – 38.06), 
except for Report 4 (score = 39.0), and Report 6, possibly 
bordering the lower confidence limit (score = 25.50). As 
indicated in Table 3, paper 4 ranked with highest score (“A” 
quality systematic review – most trustworthy consensus 
statement based on the best available evidence) ; papers 1-3, 
5 & 7 ranked within the top 80
th percentile (B quality sys-
tematic review). Papers 8-11 ranked in the 70
th percentile 
based of the aggregate R-AMSTAR scores (“C” quality sys-
tematic review), and paper 6, in this example, presents a sys-
tematic review so flawed, based on AMSTAR criteria and R-
AMSTAR quantification, that it hardly offers noteworthy 
clinical relevance.  
Table 1 also shows a significant difference in the relative 
scores for each of the eleven domains of the R-AMSTAR 
(Friedman, p<0.0001). Whereas none of the R-AMSTAR 
questions across the PTSD bibliome showed an overall mean 
score outside the 95% confidence limits, domains repre-
sented by question 5 (appropriate inclusion and exclusion of 
the literature) and 10 (publication bias) inspire caution and 
limited confidence. Domains represented by questions 4 
(gray literature) and 11 (conflict of interest) also appear rela-
tively weak. Taken together, the average scores of these four 
domains are significantly lower than the remaining stronger 
domains represented by questions 1,2,3,6,7,8 & 9 
(Wilcoxon, p=0.0002). 
Table 1. Average R-AMSTAR Scores Across 2 Independent Readers for the PTSD Literature 
Report  1  2 3 4 5 6 7 8 9  10  11   Total 
1  4.00  3.50 3.50 3.00 1.50 4.00 3.50 4.00 4.00 1.00 1.50  32.50 
2  4.00  4.00 3.50 2.50 1.50 3.00 2.50 4.00 4.00 2.50 1.00  33.00 
3  4.00  4.00 4.00 2.00 1.00 2.50 3.00 4.00 4.00 1.00 1.50  32.50 
4  4.00  2.50 4.00 4.00 4.00 4.00 4.00 4.00 3.50 4.00 3.50  39.00 
5  4.00  2.50 4.00 2.00 1.50 4.00 3.50 4.00 3.00 1.50 2.00  32.00 
6  4.00  1.00 3.50 2.00 2.00 2.50 3.00 2.50 2.00 1.50 1.50  25.50 
7  4.00  4.00 3.50 1.50 1.00 4.00 3.00 4.00 4.00 1.50 2.50  33.00 
8  4.00  1.50 3.50 1.50 1.50 4.00 2.50 4.00 2.50 1.50 3.00  29.50 
9  4.00  2.00 3.00 1.00 2.00 3.50 4.00 4.00 3.00 1.00 2.50  30.00 
10  4.00  1.00 3.50 2.00 1.00 4.00 3.00 4.00 3.00 1.50 2.00  29.00 
11  4.00  1.00 3.50 2.50 2.50 4.00 2.50 3.50 2.00 1.50 3.00  30.00 
Mean  4.00  2.45 3.59 2.18 1.77 3.59 3.14 3.82 3.18 1.68 2.18  31.45 
SD  0.00  1.25 0.30 0.81 0.88 0.63 0.55 0.46 0.78 0.87 0.78  3.37 
 (p<0.0001, Friedman non-parametric ANOVA equivalent) 
Table 2. Average R-AMSTAR Scores Across 2 Independent Readers for the RA Literature 
Reports  1 2 3 4 5 6 7 8 9  10  11 Total 
1  4.00 1.00 4.00 2.00 3.50 3.50 3.50 3.50 1.00 1.00 1.00  28.00 
2  3.50 2.50 4.00 4.00 3.50 4.00 3.50 2.50 3.50 1.50 1.00  33.50 
3  4.00 4.00 3.50 4.00 1.50 2.50 3.50 3.50 2.50 1.50 1.00  31.50 
4  4.00 2.00 4.00 4.00 2.00 4.00 3.50 3.00 3.50 1.00 1.00  32.00 
5  3.50 4.00 4.00 3.00 2.50 4.00 4.00 4.00 2.50 1.00 2.50  35.00 
Mean  3.80 2.70 3.90 3.40 2.60 3.60 3.60 3.30 2.60 1.20 1.30  32.00 
SD  0.27 1.30 0.22 0.89 0.89 0.65 0.22 0.57 1.02 0.27 0.67  2.62 
(p=0.001, Friedman non-parametric ANOVA equivalent) From Systematic Reviews to Clinical Recommendations  The Open Dentistry Journal, 2010, Volume 4    87 
A similar analysis is presented in Table 2 for the RA bib-
liome, which presents with an overall R-AMSTAR score 
CI95 (26.86 - 37.14). In contrast to the PTSD bibliome, most 
of the systematic reviews in the RA bibliome obtained an 
“A” quality of systematic review, ranking at or within the 
90
th percentile. Paper 1 ranked as a “B” quality systematic 
review (80
th percentile) (Table 3). 
Table 2 also shows a statistically significant difference in 
the relative scores among the overall scores across the eleven 
domains tested by R-AMSTAR across the RA bibliome 
(Friedman, p=0.0001). The data evince particular weak-
nesses in the field vis à vis questions 10 and 11 (gray litera-
ture inclusion and conflict of interest, respectively). The 
scores of these questions are significantly lower than the 
scores on questions 1-9 (Wilcoxon, p<0.00001). 
DISCUSSION 
The findings, presented in Tables 1-3, confirm the use-
fulness of acceptable sampling analysis in the context of 
systematic reviews. Quality of the evidence assessments, 
when performed by a well-constructed and standardized in-
strument that captures the widely accepted domains of the 
scientific process, can generate important observations with 
respect to general acceptability of reports (i.e., Tables 1 & 2 
vertical marginals: total scores), as well as inherent strengths 
and weakness of the corpus of research under examination. 
The latter are rendered by the horizontal marginal means in 
Tables 1 & 2. Table 3 presents a transformation of the in-
formation in the preceding tables in such a manner as to 
proffer a succinct and easy-to-interpret grading system (A-
D), based on the fundamental and commonly accepted con-
cept of percentile, which clinicians and third-party providers 
can use in order to evaluate at a glance the evidence synthe-
sized in he systematic review under consideration. 
The process of systematic review quality assessment, 
evaluation and dissemination we propose here relies on the 
construct, content and criterion validity of the AMSTAR 
instrument, which has been established, described and 
documented by others over the past decade (10-13). The 
AMSTAR is commonly utilized by investigators in the 
health care fields, as well as policy-making associations 
(e.g., American Dental Association, Evidence-Based Den-
tistry Center).  
Through factor analysis and psychometric characteriza-
tion, eleven domains were obtained, which constitute the 
AMSTAR. These domains are commonly accepted among 
researchers and clinicians in evidence-based health care to 
assess adequately the research synthesis stringency and the 
clinical relevance of any given systematic review. The major 
flaw of the AMSTAR instrument, however, is that it gener-
ates a qualitative evaluation, and fails to quantify the sys-
tematic review quality. 
In order to address this limitation, we utilized the criteria 
that are imbedded within each of the eleven domains of the 
original AMSTAR, and produced scores based on whether 
critical reading revealed satisfactory vs. unsatisfactory cov-
erage of each criterion. Following a series of pilot studies 
aimed at refining and adjusting the relative weight of the 
criteria within each domain, we obtained the R-AMSTAR 
(cf., Appendix 1), which preserves the construct, content and 
criterion validity of the original instrument, while permitting 
quantification.  
The quantified measures of the R-AMSTAR are scores 
on each of the individual eleven domains of the original in-
strument, based on the criteria discussed above. Each do-
main’s score ranges between 1 and 4 (maximum), and the R-
AMSTAR total scores has a range of 11 to 44 (maximum). 
By implication, a total score of 11 (e.g., Tables 1 & 2, hori-
zontal marginals) signifies that none of the AMSTAR crite-
ria were satisfied along said established eleven domains. By 
contrast, a score of 44 reveals that all of the criteria of sys-
tematic review excellence were verified in every domain. 
That is to say, low R-AMSTAR total scores should lead to 
prudence on the part of the clinician, whereas high R-
AMSTAR total scores should impart a certain degree of con-
fidence about the clinical relevance and implications of the 
findings discussed in the high scoring systematic review.  
Table 3. Systematic Review Ranking Based on R-AMSTAR 
Scores 
PICO Paper  R-AMSTAR
a %ile  Rank
b 
PTSD 1  32.50  83  B 
 2  33.00  85  B 
 3  32.50  83  B 
 4  39.00  100  A 
 5  32.00  82  B 
 6  25.50  65  D 
 7  33.00  85  B 
 8  29.50  76  C 
 9  30.00  77  C 
 5  35.00  100  A 
 11  30.00  77  C 
       
RA 1  28.00  80  B 
 2  33.50  96  A 
 3  31.50  90  A 
 4  32.00  91  A 
aThe values listed in the table correspond to the total R-AMSTAR scores 
listed in Tables 1 & 2 respectively for the PTSD and the RA bibliome 
bBased on the criteria of excellence of systematic reviews that resulted in 
the 11 domains examined by the AMSTAR, the overall score on the R-
AMSTAR, which is revised only to the extent that it produces a quantifica-
tion of the assessments of these domains, reveals the possibility to assign a 
grade of systematic review quality and clinical relevance, based on the 
criteria of the top percentile of the scores reflecting an A paper, and so on. 
The rankings are, for obvious reasons, relative strictly to the systematic 
reviews examined in response to the specific P.I.C.O. question, and thus 
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Relative to the set of systematic reviews within a given 
bibliome (e.g., here P.I.C.O. question on PTSD, and P.I.C.O. 
question on RA), a ranking of systematic review quality can 
be obtained, and graded based on the widely accepted, sim-
ple concept of percentiles: in that manner, most of the sys-
tematic reviews responding to the RA P.I.C.O. question were 
deserving of an “A” grade. “A” grade systematic reviews are 
those that adhere stringently to commonly shared principles 
of clinical relevance; therefore, “A” grade systematic re-
views are those, which clinicians can use with the greatest 
degree of confidence in the process of making evidence-
based clinical decisions. It is of note that in both example 
bibliomes examined here, the top-ranking systematic reviews 
were not, as one might expect uniformally, Cochrane re-
views. 
The methodological strength of the R-AMSTAR further 
rests on the fact that an acceptable sampling analysis may be 
conducted both along the vertical marginal totals (i.e., total 
scores), which, by the adoption of some conventional crite-
rion cut-off point (e.g., total score of 22, which indicates 
that, on average, only two criteria for each of the domains 
tested were satisfied), permits the exclusion of low scoring 
systematic reviews. This process, which might not be rec-
ommended in all cases, such as, for example, when a Baye-
sian interpretation of the best available evidence is sought, is 
useful in specific cases of the construction of complex sys-
tematic reviews (aka, meta-systematic reviews, 3,8). 
Furthermore, analysis of the marginal means and stan-
dard deviations (horizontal marginal values in Tables 2 & 3), 
yields valuable information with respect to the relative 
strength or weakness of a bibliome along each given domain 
(Tables 1 & 2). When the reports within a bibliome are uni-
formly strong (or weak) along the eleven AMSTAR do-
mains, then the Friedman analysis of the tabulated scores 
reveals no statistical significance. A significant Friedman 
analysis, such as those evinced in both Tables 1 & 2, indi-
cates that certain domains are strong and acceptable, while 
others are alarmingly weak and can seriously jeopardize the 
clinical relevance of the systematic reviews that overall con-
stitute the bibliome under study. Further post-hoc analysis 
proffers the ability to identify these weaknesses, such that 
the alerted clinician, can, if so desiring, use in the clinical 
decision-making process even “B” or “C” systematic re-
views, so long as the recommendations are interpreted in 
light of the identified limitations through the acceptable 
sampling analysis protocol just described. 
Taken together, the analyses we present here improve 
and expand the use of the commonly accepted AMSTAR 
instrument (11,13) by enabling reliable quantification of the 
eleven domains taken to represent clinical relevance of sys-
tematic reviews. Our approach (9) permits a detailed analysis 
of acceptable vs. deficient aspects of each systematic review 
within any given bibliome obtained in answering a specific 
P.I.C.O. question, as well as the overall strengths and limita-
tions of the bibliome as a corpus of literature. Furthermore, 
the R-AMSTAR we describe here (Appendix 1) yields a 
total score, which proffers the ability to rank and grade each 
systematic review relative to each other in the bibliome un-
der study (Table 3). The clinical utility of the A-through-D 
grades thus obtained, which are easy to grasp for use in evi-
dence-based clinical decision-making, and based on the sim-
ple principle of percentiles, rests on the fact that their inter-
pretation is reflective of the clinical relevance of any system-
atic review within the bibliome.  
It is also the case that, in absolute terms, the overall total 
score of the R-AMSTAR reflects the adherence of any sys-
tematic review under evaluation to the generally accepted 
criteria of quality of the synthesized evidence, regardless of 
the P.I.C.O. question. That is to say, it is possible and even 
probable that the translation of the scores into percentile, as 
we propose in Table 3 relative to individual specific P.I.C.O. 
questions, can be generalized. A random (rather than fixed) 
interpretative model of the R-AMSTAR quantifications will 
bring much needed cohesion and uniformity to the field of 
evidence-based decision-making. In conclusion, the R-
AMSTAR yields numbers based upon generally agreed upon 
criteria of excellence, which can be transformed into a stan-
dardized grading system of the quality of the evidence pre-
sented in any given systematic review (cf., Table 3); and, 
such transformation can be generalized across the entire bib-
liome of research synthesis in clinical dentistry to yield a 
simple, reliable, and easy-to-grasp quantification of the qual-
ity of the evidence for any systematic review under consid-
eration. 
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APPENDIX 1 
Revised Amstar 
 
1. Was an ‘a priori’ design provided?  
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 of the criteria 1  From Systematic Reviews to Clinical Recommendations  The Open Dentistry Journal, 2010, Volume 4    89 
       Criteria: 
(A)  ‘a priori’ design 
(B)  statement of inclusion criteria 
(C)  PICO/PIPO research question (population, intervention, comparison, prediction, outcome) 
 
2. Was there duplicate study selection and data extraction? 
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 of the criteria 1  
       Criteria: 
(A)  There should be at least two independent data extractors as stated or implied. 
(B)  Statement of recognition or awareness of consensus procedure for disagreements. 
(C)  Disagreements among extractors resolved properly as stated or implied 
 
3. Was a comprehensive literature search performed? 
If it satisfies 4 or 5 of the criteria  4 
If it satisfies 3 of the criteria  3 
If it satisfies 2 of the criteria 2 
If it satisfies 1 or 0 of the criteria  17 
       Criteria:  
(A)  At least two electronic sources should be searched. 
(B)  The report must include years and databases used (e.g. Central, EMBASE, and MEDLINE).  
(C)  Key words and/or MESH terms must be stated AND where feasible the search strategy outline should be provided such that 
one can trace the filtering process of the included articles. 
(D)  In addition to the electronic databases (PubMed, EMBASE, Medline), all searches should be supplemented by consulting 
current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the 
references in the studies found. 
(E)  Journals were “hand-searched” or “manual searched”  (i.e. identifying highly relevant journals and conducting a manual, 
page-by-page search of their entire contents looking for potentially eligible studies) 
 
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? 
(Grey literature is literature produced at all levels of government, academia, business and industry in print and electronic for-
mats, but is not controlled by commercial publishers. Examples can be but not limited to dissertations, conference proceedings.) 
Here is an extra description of what grey literature is. 
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 of the criteria 1  
       Criteria:  
(A)  The authors should state that they searched for reports regardless of their publication type.  
(B)  The authors should state whether or not they excluded any reports (from the systematic review), based on their publication 
status, language etc. 
(C)  “Non-English papers were translated” or readers sufficiently trained in foreign language 
(D)  No language restriction or recognition of non-English articles 
 
5. Was a list of studies (included and excluded) provided? 
If it satisfies 4 of the criteria 4 
If it satisfies 3 of the criteria 3 
If it satisfies 2 of the criteria 2 
If it satisfies 1 or 0 of the criteria  1 
       Criteria: 90    The Open Dentistry Journal, 2010, Volume 4  Kung et al. 
(A)  Table/list/or figure of included studies, a reference list does not suffice. 
(B)  Table/list/figure of excluded studies
1 either in the article or in a supplemental source (i.e. online). (Excluded studies refers to 
those studies seriously considered on the basis of title and/or abstract, but rejected after reading the body of the text) 
(C)  Author satisfactorily/sufficiently stated the reason for exclusion of the seriously considered studies.  
(D)  Reader is able to retrace the included and the excluded studies anywhere in the article bibliography, reference, or 
supplemental source 
 
6. Were the characteristics of the included studies provided? 
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 criteria  1  
       Criteria: 
(A)  In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions 
AND outcomes. 
(B)  Provide the ranges of relevant characteristics in the studies analyzed (e.g. age, race, sex, relevant socioeconomic data, 
disease status, duration, severity, or other diseases should be reported.) 
(C)  The information provided appears to be complete and accurate (i.e. there is a tolerable range of subjectivity here. Is the reader 
left wondering? If so, state the needed information and the reasoning). 
 
7. Was the scientific quality of the included studies assessed and documented?  
If it satisfies 4 of the criteria 4 
If it satisfies 3 of the criteria 3 
If it satisfies 2 of the criteria 2 
If it satisfies 1 or 0 of the criteria  1  
       Criteria:  
(A)  ‘A priori’ methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to include only 
randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion criteria); for other types of 
studies alternative items will be relevant. 
(B)  The scientific quality of the included studies appears to be meaningful. 
(C)  Discussion/recognition/awareness of level of evidence  
(D)  Quality of evidence should be rated/ranked based on characterized instruments. (Characterized instrument is a created 
instrument that ranks the level of evidence, e.g. GRADE[Grading of Recommendations Assessment, Development and 
Evaluation.]) 
 
8. Was the scientific quality of the included studies used appropriately in formulating conclusions?  
If it satisfies 4 of the criteria 4 
If it satisfies 3 of the criteria 3 
If it satisfies 2 of the criteria 2 
If it satisfies 1 or 0 of the criteria  1  
      Criteria:  
(A)  The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions 
of the review 
(B)  The results of the methodological rigor and scientific quality are explicitly stated in formulating recommendations.  
(C)  To have conclusions integrated/drives towards a clinical consensus statement  
(D)  This clinical consensus statement drives toward revision or confirmation of clinical practice guidelines 
 
9. Were the methods used to combine the findings of studies appropriate? 
If it satisfy 4 of the criteria  4 
If it satisfy 3 of the criteria  3 
If it satisfy 2 of the criteria  2 
                                                 
1 It is worth to have a brief overview of the excluded studies, since they do present relevant clinical information. From Systematic Reviews to Clinical Recommendations  The Open Dentistry Journal, 2010, Volume 4    91 
If it satisfy 1 or 0 of the following criteria  1 
      Criteria:  
(A)  Statement of criteria that were used to decide that the studies analyzed were similar enough to be pooled? 
(B)  For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (i.e. 
Chi-squared test for homogeneity, I).  
(C)  Is there a recognition of heterogeneity or lack of thereof 
(D)  If heterogeneity exists a “random effects model” should be used and/or the rationale (i.e. clinical appropriateness) of 
combining should be taken into consideration (i.e. is it sensible to combine?), or stated explicitly  
(E)  If homogeneity exists, author should state a rationale or a statistical test 
 
10. Was the likelihood of publication bias (a.k.a. “file drawer” effect) assessed? 
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 of the criteria 1  
        Criteria:  
(A)  Recognition of publication bias or file-drawer effect 
(B)  An assessment of publication bias should include graphical aids (e.g., funnel plot, other available tests)  
(C)  Statistical tests (e.g., Egger regression test). 
 
11. Was the conflict of interest stated? 
If it satisfies 3 of the criteria 4 
If it satisfies 2 of the criteria 3 
If it satisfies 1 of the criteria 2 
If it satisfies 0 of the criteria 1  
       Criteria:  
(A)  Statement of sources of support 
(B)  No conflict of interest. This is subjective and may require some deduction or searching.  
(C)  An awareness/statement of support or conflict of interest in the primary inclusion studies 
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